Cancer Immunotherapy Today: Maximizing Patient Outcomes

May 31 from 12:30 PM-5:00 PM and June 1 from 7:30 AM-11:00 AM
McCormick Place, Room S100bc

Seminar Description

This seminar enables clinical oncologists, nurses, pharmacists, and the entire medical team to effectively offer their patients additional treatment options through immunotherapy. Advances in cancer immunotherapy research are rapidly emerging, with an increasing rate of new approvals for the routine clinical use of immunotherapy agents in the clinic across a variety of cancers. The pace of progress in the field necessitates the continuing education of oncology clinicians to enable them to provide the most up-to-date and comprehensive immunotherapy-based treatment options to their patients. In addition, oncologists, nurses and pharmacists with basic knowledge related to utilizing immunotherapy in clinical practice continue to be challenged by issues related to patient selection and toxicity management. This seminar will be co-sponsored with the Society for Immunotherapy of Cancer (SITC).

This course qualifies for physician, nursing, and pharmacist credits.  Further information can be found below.

Seminar Agenda

Note: Session faculty will be added to the agenda below as presenters are confirmed.

Day 1: Thursday, May 31, 2018: 12:30 PM - 5:00 PM

12:30 PM - 1:00 PM Lunch
1:00 PM - 1:25 PM

Session 1: Basic Principles of Immunotherapy

 

TBD
Immunotherapy Basics

 

Panel Question and Answer

1:25 PM - 2:55 PM

Session 2: Integrating Immunotherapy Into Clinical Practice—Changes Over the Past Year (Part 1)

 

TBD
Melanoma and Other Skin Cancers

 

Question and Answer

 

Naiyer A. Rizvi, MD
Columbia University Medical Center
Lung Cancer

 

Question and Answer

 

Leisha A. Emens, MD, PhD
The Johns Hopkins University
Breast and Gynecologic Cancers

 

Question and Answer

2:55 PM - 3:10 PM Break
3:10 PM - 5:00 PM

Session 2: Integrating Immunotherapy Into Clinical Practice—Changes Over the Past Year (Part 2)

 

TBD
Gastrointestinal Cancers

 

Question and Answer

 

Neeraj Agarwal, MD
Huntsman Cancer Institute at the University of Utah
Genitourinary Cancers

 

Question and Answer

 

Robert L. Ferris, MD, PhD, FACS
University of Pittsburgh Medical Center and University of Pittsburgh Cancer Institute
Head and Neck Cancers

 

Question and Answer

 

Alexander I. Spira, MD, PhD, FACP
Virginia Cancer Specialists Research Institute and Oncology Research
The Impact of Immunotherapy On A Community Practice

Question and Answer

 

Day 2: Friday, June 1, 2018: 7:00 AM - 11:00 AM

7:00 AM - 7:30 AM Breakfast
7:30 AM - 8:15 AM

Session 3: Hematologic Malignancies and CAR-T Cell Therapy

 

John Timmerman, MD
University of California, Los Angeles
Hematologic Malignancies

 

TBD
Clinical Application of Cell Therapies: Mechanism of Action, Efficacy, and Patient Selection

 

Panel Question and Answer

8:15 AM - 8:30 AM Break
8:30 AM - 10:30 AM

Session 4: Managing Immune-Related Adverse Events—The Challenge to Maximize the Risk/Benefit Ratio

*A case-based panel discussion

Ravi A. Madan, MD—Chair
National Cancer Institute

10:30 AM - 11:00 AM

Session 5: The Future of Immunotherapy—Novel Agents in Clinical Trials

 

TBD
New Agents in Clinical Trials: Significant Phase I-III Clinical Trials

 

Panel Question and Answer

 

Seminar Committee

View Seminar Committee Disclosures

Leisha Emens, MD, PhD​ (Co-Chair)​
Johns Hopkins University

Mario Sznol, MD (Co-Chair)​
Yale School of Medicine

Marc S. Ernstoff, MD
Roswell Park Cancer Institute

Doreen Higgins, RN, BSN, CCRP
University of Washington

Ravi Madan, MD
National Cancer Institute/National Institute of Health

Lowell E. Schnipper, MD, FASCO
Beth Israel Deaconess Medical Center

Eleni Yeatras, RPh, BCOP
Sibley Memorial Hospital

Accreditation 

In support of improving patient care, the American Society of Clinical Oncology is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Target Audience

The 2018 Cancer Immunotherapy Today: Maximizing Patient Outcomes Seminar is designed for the cancer care team; credit is offered for physicians, nurses, and pharmacists, but all are encouraged to participate, as they may be able to apply for credit through their own licensing organization.

Disclaimer/Unlabeled Usage Statement         

The information presented is that of the contributing authors and does not necessarily represent the views of the American Society of Clinical Oncology and/or any named commercial entity providing financial support. Specific therapies discussed may not be approved and/or specified for use as indicated. Therefore, before prescribing any medication, please review the complete prescribing information including indications, contraindications, warnings, precautions and adverse effects.